These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7932924)

  • 1. Visceral leishmaniasis: new foci of infection in Libya.
    Mehabresh MI
    J Trop Med Hyg; 1994 Oct; 97(5):282-5. PubMed ID: 7932924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis in Libya--review of 21 cases.
    Mehabresh MI; el-Mauhoub MM
    Ann Trop Paediatr; 1992; 12(2):159-63. PubMed ID: 1381890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study among cutaneous leishmaniasis cases in Tripoli Central Hospital, Tripoli, Libya.
    El Buni AA; Edwebi H; Ben Darif AL
    Arch Inst Pasteur Tunis; 1997; 74(1-2):3-4. PubMed ID: 15945169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis in Omani children: a review.
    Elnour IB; Akinbami FO; Shakeel A; Venugopalan P
    Ann Trop Paediatr; 2001 Jun; 21(2):159-63. PubMed ID: 11471261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral Leishmaniasis in children in the Yemen.
    Haidar NA; Diab AB; El-Sheik AM
    Saudi Med J; 2001 Jun; 22(6):516-9. PubMed ID: 11426243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kala azar in an adult Libyan and review of visceral leishmaniasis in Libya.
    Jain S; el Mangoush MA; el-Bouri K; Mahfouz MO
    Trop Geogr Med; 1990 Jul; 42(3):283-5. PubMed ID: 2293439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
    Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
    Sundar S; More DK; Singh MK; Singh VP; Sharma S; Makharia A; Kumar PC; Murray HW
    Clin Infect Dis; 2000 Oct; 31(4):1104-7. PubMed ID: 11049798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis in Kenyan children.
    Anabwani GM; Bryceson AD
    Indian Pediatr; 1982 Oct; 19(10):819-22. PubMed ID: 6298111
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of megaloblastic anaemia and its correction in leishmaniasis--a prospective study at BPKIHS hospital, Nepal.
    Sinha AK; Rijal S; Karki P; Majhi S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):528-31. PubMed ID: 17183843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
    Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
    Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug regimens for visceral leishmaniasis in Mediterranean countries.
    Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
    Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An infant with 5 weeks of fever of unknown origin and a reasonably good clinical condition; leishmaniasis].
    Wijburg HC; van Wieringen PM; van der Zee CL
    Ned Tijdschr Geneeskd; 1990 Jul; 134(29):1409-12. PubMed ID: 2165220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.